Business Context and Reporting Period
This Form 8-K is filed by Bond Laboratories, Inc. (not Fitlife Brands, Inc.) for the reporting period ending September 30, 2009. The company is a Nevada corporation headquartered in Omaha, NE. The filing primarily reports on a completed private financing transaction and a debt-for-equity exchange.
Key Financial Metrics
The filing details specific capital raising activities rather than standard operating metrics like revenue or net income.
- Total Capital Raised: $1,684,450 in cash from private investors.
- Debt Converted to Equity: $123,000 of outstanding demand notes and trade payables.
- Shares Issued (Cash): 3,368,900 common shares.
- Shares Issued (Debt Exchange): 246,000 common shares.
- Warrants Issued: Series B warrants to purchase 3,614,900 shares total (3,368,900 + 246,000).
- Warrant Terms: Exercise price of $0.75 per share; three-year term; no anti-dilution or pre-emptive rights.
Note: The filing text does not provide clear values for revenue, profit, cash flow, margins, or total debt levels outside of the specific $123,000 converted.
Material Changes
The primary material change is the significant increase in outstanding common stock and the reduction of specific liabilities.
- Equity Dilution: Issuance of 3,614,900 new shares of common stock.
- Liability Reduction: Elimination of $123,000 in debt and trade payables through conversion.
- Liquidity Improvement: Inflow of $1,684,450 in cash proceeds.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure of the unregistered sale of securities.
- Transaction Status: The financing was completed on September 30, 2009.
- Regulatory Basis: Securities were issued under exemptions Sections 4(2) and 4(6) of the Securities Act of 1933 and Rule 506 of Regulation D.
Investor Verification Checklist
- Verify the total number of outstanding shares post-issuance to assess dilution impact.
- Confirm the use of the $1,684,450 cash proceeds (not detailed in this 8-K).
- Review the company's balance sheet to determine the remaining debt load after the $123,000 conversion.
- Check subsequent filings for the exercise status of the 3.6 million Series B warrants.